Literature DB >> 17128989

N- and C-terminal hydrophobic patches are involved in fibrillation of glucagon.

Jesper Søndergaard Pedersen1, Dancho Dikov, Daniel Erik Otzen.   

Abstract

Recent work suggests that the molecular structure of amyloid-like fibrils is determined by environmental conditions as well as amino acid sequence. To probe the involvement of side chains in fibrillation of the 29-residue hormone glucagon, we have measured fibrillation kinetics of 15 alanine mutants. At acidic pH, all of the mutants are able to form fibrils. However, substitution of hydrophobic residues in the N- and C-termini (in particular Phe6, Tyr10, Val23, and Met27) decelerates fibrillation dramatically. This indicates that the hydrophobicity and/or high beta-sheet propensity of these residues may be important for fibrillation. In contrast, substitution of Leu14 increases fibrillation propensity compared to that of the wild type. Nevertheless, despite identical fibrillation conditions, the thioflavin T and tryptophan fluorescence spectra of fibrils formed by mutants Tyr13, Leu14, and Asp15 are significantly different from those of other mutants, indicating that substitution of these residues may influence not only the fibrillation kinetics and fibril stability but also the preferred final structure of the fibrils that is formed, in line with the general structural polymorphism of glucagon fibrils. In contrast, under alkaline conditions, only a handful of the alanine mutants are capable of forming fibrils, suggesting that more side chains are involved in stabilizing interactions here. In addition, fibrils formed by wild-type glucagon at alkaline pH appear very stable, compared to fibrils formed at acidic pH. This suggests that the distribution of charges determines the number of different fibrillated states available to a peptide, since these can block formation of metastable fibrillated states.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17128989     DOI: 10.1021/bi061228n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

Review 1.  The nature of amyloid-like glucagon fibrils.

Authors:  Jesper Søndergaard Pedersen
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

Review 2.  Amyloid-a state in many guises: survival of the fittest fibril fold.

Authors:  Jesper S Pedersen; Daniel E Otzen
Journal:  Protein Sci       Date:  2007-11-27       Impact factor: 6.725

3.  Early stages of amyloid fibril formation studied by liquid-state NMR: the peptide hormone glucagon.

Authors:  Anna Sigrid Pii Svane; Kasper Jahn; Taru Deva; Anders Malmendal; Daniel Erik Otzen; Jens Dittmer; Niels Chr Nielsen
Journal:  Biophys J       Date:  2008-03-13       Impact factor: 4.033

4.  Model discrimination and mechanistic interpretation of kinetic data in protein aggregation studies.

Authors:  Joseph P Bernacki; Regina M Murphy
Journal:  Biophys J       Date:  2009-04-08       Impact factor: 4.033

5.  Photolytic labeling to probe molecular interactions in lyophilized powders.

Authors:  Lavanya K Iyer; Balakrishnan S Moorthy; Elizabeth M Topp
Journal:  Mol Pharm       Date:  2013-10-29       Impact factor: 4.939

6.  Uncommon Peptide Bond Cleavage of Glucagon from a Specific Vendor under near Neutral to Basic Conditions.

Authors:  Hong-Jian Zheng; Bin-Bin Shen; Jing Wang; Haibin Wang; Guo-Li Huo; Li-Rui Huang; Jian-Qing Gao; Wei-Jie Fang
Journal:  Pharm Res       Date:  2019-06-03       Impact factor: 4.200

7.  Mechanisms of glucagon degradation at alkaline pH.

Authors:  Nicholas Caputo; Jessica R Castle; Colin P Bergstrom; Julie M Carroll; Parkash A Bakhtiani; Melanie A Jackson; Charles T Roberts; Larry L David; W Kenneth Ward
Journal:  Peptides       Date:  2013-05-04       Impact factor: 3.750

8.  Biochemical stabilization of glucagon at alkaline pH.

Authors:  Nicholas Caputo; Melanie A Jackson; Jessica R Castle; Joseph El Youssef; Parkash A Bakhtiani; Colin P Bergstrom; Julie M Carroll; Matthew E Breen; Gerald L Leonard; Larry L David; Charles T Roberts; W Kenneth Ward
Journal:  Diabetes Technol Ther       Date:  2014-06-26       Impact factor: 6.118

Review 9.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

10.  Fibrillation of the major curli subunit CsgA under a wide range of conditions implies a robust design of aggregation.

Authors:  Morten S Dueholm; Søren B Nielsen; Kim L Hein; Poul Nissen; Matthew Chapman; Gunna Christiansen; Per Halkjær Nielsen; Daniel E Otzen
Journal:  Biochemistry       Date:  2011-09-12       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.